(+)-schisandrin B multiple interactions ISO RGD:70918 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of KLF15 mRNA] CTD PMID:31150632 17alpha-ethynylestradiol affects expression ISO RGD:70918 6480464 Ethinyl Estradiol affects the expression of KLF15 mRNA CTD PMID:17351261 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of KLF15 mRNA CTD PMID:25210133 17beta-estradiol multiple interactions ISO RGD:737261 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of KLF15 mRNA CTD PMID:30165855 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:737261 6480464 Dihydrotestosterone results in increased expression of KLF15 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of KLF15 mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:70918 6480464 Tetrachlorodibenzodioxin results in increased expression of KLF15 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737261 6480464 Tetrachlorodibenzodioxin results in decreased expression of KLF15 mRNA CTD PMID:28011154 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:70918 6480464 Tetrachlorodibenzodioxin results in decreased expression of KLF15 mRNA CTD PMID:21215274 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:70918 6480464 Tetrachlorodibenzodioxin affects the expression of KLF15 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737261 6480464 Tetrachlorodibenzodioxin results in increased expression of KLF15 mRNA CTD PMID:21296121 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KLF15 mRNA CTD PMID:19465110 2,4-dinitrotoluene affects expression ISO RGD:70918 6480464 2, 4-dinitrotoluene affects the expression of KLF15 mRNA CTD PMID:21346803 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of KLF15 mRNA CTD PMID:30496566 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of KLF15 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of KLF15 mRNA CTD PMID:28973697 acrylamide increases expression ISO RGD:70918 6480464 Acrylamide results in increased expression of KLF15 mRNA CTD PMID:28959563 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of KLF15 mRNA CTD PMID:19770486 AICA ribonucleotide decreases expression EXP 6480464 AICA ribonucleotide results in decreased expression of KLF15 mRNA CTD PMID:24428821 amiodarone increases expression ISO RGD:737261 6480464 Amiodarone results in increased expression of KLF15 mRNA CTD PMID:19774075 ammonium chloride affects expression ISO RGD:70918 6480464 Ammonium Chloride affects the expression of KLF15 mRNA CTD PMID:16483693 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of KLF15 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:737261 6480464 Benzo(a)pyrene results in decreased expression of KLF15 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:737261 6480464 Benzo(a)pyrene results in increased methylation of KLF15 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:737261 6480464 Benzo(a)pyrene results in decreased methylation of KLF15 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of KLF15 mRNA CTD PMID:21569818 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:737261 6480464 Diethylhexyl Phthalate results in decreased expression of KLF15 mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:70918 6480464 bisphenol A results in increased expression of KLF15 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:737261 6480464 bisphenol A results in decreased methylation of KLF15 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KLF15 mRNA CTD PMID:33221593 bisphenol A increases methylation ISO RGD:70918 6480464 bisphenol A results in increased methylation of KLF15 gene CTD PMID:28505145 bromobenzene increases expression ISO RGD:70918 6480464 bromobenzene results in increased expression of KLF15 mRNA CTD PMID:32479839 buspirone increases expression ISO RGD:70918 6480464 Buspirone results in increased expression of KLF15 mRNA CTD PMID:24136188 buta-1,3-diene increases expression EXP 6480464 1, 3-butadiene results in increased expression of KLF15 mRNA CTD PMID:29038090 butanal decreases expression ISO RGD:737261 6480464 butyraldehyde results in decreased expression of KLF15 mRNA CTD PMID:26079696 C60 fullerene decreases expression ISO RGD:70918 6480464 fullerene C60 results in decreased expression of KLF15 mRNA CTD PMID:19167457 carbamazepine affects expression ISO RGD:737261 6480464 Carbamazepine affects the expression of KLF15 mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chloroprene increases expression ISO RGD:70918 6480464 Chloroprene results in increased expression of KLF15 mRNA CTD PMID:23125180 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of KLF15 mRNA CTD PMID:23125180 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KLF15 gene CTD PMID:20938992 cyclosporin A increases expression ISO RGD:737261 6480464 Cyclosporine results in increased expression of KLF15 mRNA CTD PMID:19159671 cyclosporin A decreases expression ISO RGD:737261 6480464 Cyclosporine results in decreased expression of KLF15 mRNA CTD PMID:25562108 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of KLF15 mRNA CTD PMID:22936724 diazinon increases methylation ISO RGD:737261 6480464 Diazinon results in increased methylation of KLF15 gene CTD PMID:22964155 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLF15 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:737261 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:737261 6480464 Doxorubicin results in decreased expression of KLF15 mRNA CTD PMID:29803840 endosulfan increases expression ISO RGD:70918 6480464 Endosulfan results in increased expression of KLF15 mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:737261 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF15 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:737261 6480464 entinostat results in increased expression of KLF15 mRNA CTD PMID:26272509 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of KLF15 mRNA CTD PMID:35436446 ethanol multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of KLF15 mRNA CTD PMID:30517762 ethanol affects expression EXP 6480464 Ethanol affects the expression of KLF15 mRNA CTD PMID:30319688 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KLF15 gene CTD PMID:20938992 gentamycin increases expression ISO RGD:70918 6480464 Gentamicins results in increased expression of KLF15 mRNA CTD PMID:33387578 hexadecanoic acid multiple interactions ISO RGD:70918 6480464 CXCL12 protein inhibits the reaction [Palmitic Acid results in decreased expression of KLF15 protein] more ... CTD PMID:34310909 hexadecanoic acid decreases expression ISO RGD:70918 6480464 Palmitic Acid results in decreased expression of KLF15 protein CTD PMID:34310909 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of KLF15 mRNA CTD PMID:20003209 ketamine increases expression ISO RGD:70918 6480464 Ketamine results in increased expression of KLF15 mRNA CTD PMID:20080153 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KLF15 gene CTD PMID:20938992 leflunomide increases expression ISO RGD:70918 6480464 leflunomide results in increased expression of KLF15 mRNA CTD PMID:24136188 levofloxacin increases expression ISO RGD:70918 6480464 Levofloxacin results in increased expression of KLF15 mRNA CTD PMID:24136188 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine results in increased expression of KLF15 mRNA], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine results in increased expression of KLF15 protein] CTD PMID:32639145 metformin decreases expression EXP 6480464 Metformin results in decreased expression of KLF15 mRNA CTD PMID:24428821 methamphetamine increases expression ISO RGD:70918 6480464 Methamphetamine results in increased expression of KLF15 protein CTD PMID:35863504 methapyrilene decreases expression ISO RGD:70918 6480464 Methapyrilene results in decreased expression of KLF15 mRNA CTD PMID:30467583 methylmercury chloride increases expression ISO RGD:737261 6480464 methylmercuric chloride results in increased expression of KLF15 mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of KLF15 mRNA CTD PMID:25543134 Muraglitazar increases expression ISO RGD:70918 6480464 muraglitazar results in increased expression of KLF15 mRNA CTD PMID:21515302 N-methyl-4-phenylpyridinium increases expression ISO RGD:737261 6480464 1-Methyl-4-phenylpyridinium results in increased expression of KLF15 mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium increases expression ISO RGD:70918 6480464 1-Methyl-4-phenylpyridinium results in increased expression of KLF15 mRNA CTD PMID:28801915 naphthalene increases expression EXP 6480464 naphthalene results in increased expression of KLF15 mRNA CTD PMID:18978301 nefazodone increases expression ISO RGD:70918 6480464 nefazodone results in increased expression of KLF15 mRNA CTD PMID:24136188 nevirapine increases expression ISO RGD:70918 6480464 Nevirapine metabolite results in increased expression of KLF15 mRNA CTD PMID:23947594 nickel atom decreases expression ISO RGD:737261 6480464 Nickel results in decreased expression of KLF15 mRNA CTD PMID:24768652 , PMID:25583101 O-methyleugenol decreases expression ISO RGD:737261 6480464 methyleugenol results in decreased expression of KLF15 mRNA CTD PMID:32234424 oxaliplatin multiple interactions ISO RGD:70918 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of KLF15 mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:70918 6480464 oxaliplatin results in increased expression of KLF15 mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:70918 6480464 Ozone results in decreased expression of KLF15 mRNA CTD PMID:16716893 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of KLF15 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of KLF15 mRNA CTD PMID:34911549 panobinostat increases expression ISO RGD:737261 6480464 panobinostat results in increased expression of KLF15 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:737261 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF15 mRNA CTD PMID:27188386 paracetamol decreases expression ISO RGD:737261 6480464 Acetaminophen results in decreased expression of KLF15 mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:70918 6480464 Acetaminophen results in increased expression of KLF15 mRNA CTD PMID:33387578 paraquat decreases expression ISO RGD:70918 6480464 Paraquat results in decreased expression of KLF15 mRNA CTD PMID:32680482 paraquat increases expression EXP 6480464 Paraquat results in increased expression of KLF15 mRNA CTD PMID:21463325 parathion increases expression EXP 6480464 Parathion results in increased expression of KLF15 mRNA CTD PMID:34813904 perfluorooctanoic acid increases expression ISO RGD:70918 6480464 perfluorooctanoic acid results in increased expression of KLF15 mRNA CTD PMID:28511854 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of KLF15 mRNA CTD PMID:19270015 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of KLF15 mRNA CTD PMID:17426115 potassium bromate affects expression EXP 6480464 potassium bromate affects the expression of KLF15 mRNA CTD PMID:27082013 potassium bromate multiple interactions EXP 6480464 [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of KLF15 mRNA] CTD PMID:27082013 progesterone increases expression ISO RGD:70918 6480464 Progesterone results in increased expression of KLF15 mRNA CTD PMID:20726854 propanal decreases expression ISO RGD:737261 6480464 propionaldehyde results in decreased expression of KLF15 mRNA CTD PMID:26079696 prothioconazole increases expression ISO RGD:737261 6480464 prothioconazole results in increased expression of KLF15 mRNA CTD PMID:35048155 quercetin affects expression ISO RGD:70918 6480464 Quercetin affects the expression of KLF15 mRNA CTD PMID:18178720 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of KLF15 mRNA CTD PMID:25338179 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:737261 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of KLF15 mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO RGD:737261 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sevoflurane affects expression ISO RGD:70918 6480464 sevoflurane affects the expression of KLF15 mRNA CTD PMID:15967596 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of KLF15 mRNA CTD PMID:23221170 silver atom decreases expression EXP 6480464 Silver results in decreased expression of KLF15 mRNA CTD PMID:27131904 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of KLF15 mRNA CTD PMID:27131904 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of KLF15 mRNA CTD PMID:27862939 streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin] promotes the reaction [KLF15 gene mutant form results in increased expression of CCN2 protein] more ... CTD PMID:34310909 sunitinib increases expression ISO RGD:737261 6480464 Sunitinib results in increased expression of KLF15 mRNA CTD PMID:31533062 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of KLF15 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression ISO RGD:70918 6480464 Carbon Tetrachloride results in decreased expression of KLF15 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of KLF15 mRNA CTD PMID:30517762 tetrachloromethane multiple interactions ISO RGD:70918 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of KLF15 mRNA] CTD PMID:31150632 thimerosal increases expression ISO RGD:737261 6480464 Thimerosal results in increased expression of KLF15 mRNA CTD PMID:27188386 thioacetamide decreases expression ISO RGD:70918 6480464 Thioacetamide results in decreased expression of KLF15 mRNA CTD PMID:34492290 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of KLF15 mRNA CTD PMID:23557971 titanium dioxide decreases expression ISO RGD:70918 6480464 titanium dioxide results in decreased expression of KLF15 mRNA CTD PMID:30012374 topotecan multiple interactions ISO RGD:70918 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of KLF15 mRNA CTD PMID:25729387 tributylstannane decreases expression ISO RGD:737261 6480464 tributyltin results in decreased expression of KLF15 mRNA CTD PMID:28011154 trichloroethene increases expression ISO RGD:70918 6480464 Trichloroethylene results in increased expression of KLF15 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:737261 6480464 trichostatin A results in increased expression of KLF15 mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:737261 6480464 Triclosan results in decreased expression of KLF15 mRNA CTD PMID:30510588 triphenyl phosphate increases expression ISO RGD:70918 6480464 triphenyl phosphate results in increased expression of KLF15 mRNA CTD PMID:30589522 triptonide affects expression EXP 6480464 triptonide affects the expression of KLF15 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:70918 6480464 troglitazone results in increased expression of KLF15 mRNA CTD PMID:21515302 urethane decreases expression ISO RGD:737261 6480464 Urethane results in decreased expression of KLF15 mRNA CTD PMID:28818685 ursodeoxycholic acid increases expression ISO RGD:70918 6480464 Ursodeoxycholic Acid results in increased expression of KLF15 mRNA CTD PMID:15885361 valdecoxib decreases expression ISO RGD:70918 6480464 valdecoxib results in decreased expression of KLF15 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:737261 6480464 Valproic Acid affects the expression of KLF15 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:737261 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF15 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:737261 6480464 Valproic Acid results in increased expression of KLF15 mRNA CTD PMID:24383497 more ... vancomycin increases expression EXP 6480464 Vancomycin results in increased expression of KLF15 mRNA CTD PMID:18930951 zinc atom increases expression ISO RGD:70918 6480464 Zinc results in increased expression of KLF15 mRNA CTD PMID:17074742 zinc sulfate increases expression ISO RGD:70918 6480464 Zinc Sulfate results in increased expression of KLF15 mRNA CTD PMID:17074742 zinc(0) increases expression ISO RGD:70918 6480464 Zinc results in increased expression of KLF15 mRNA CTD PMID:17074742
